Clinical Trials in Austin

Showing 4661-4680 of 15,205 trials

A Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction Potential After Single and Multiple Doses in Healthy Volunteers

NCT06672900

This Phase 1 study consists of two parts, all conducted in healthy volunteers (HVs). In Part 1, the drug-drug interaction (DDI) potential of ALG-000184 will be explored with Itraconazole; participants will be assigned to receive multiple doses of ALG-000184 and Itraconazole over a two week period. In Part 2, the drug-drug interaction (DDI) potential of ALG-000184 will be explored with Carbamazepine; participants will be assigned to receive multiple doses of ALG-000184 and ascending doses of Carbamazepine over an 18 day period. The 2 parts may be conducted in parallel.

Healthy Volunteer

Aligos Therapeutics24 participantsStarted Jan 2025

Austin, Texas, United States

COMPLETEDNA29 miles

Effects of Sodium Intake on Arterial Stiffness in Black Men and Women

NCT05815043

The purpose of this study is to explore the influence of sodium intake on arterial stiffness in African American/Black adults.

Sodium IntakeArterial Stiffness

Texas State University34 participantsStarted Dec 2022

San Marcos, Texas, United States

COMPLETEDPhase 174 miles

A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function

NCT02524717

The purpose of this study is to characterize the pharmacokinetics of JNJ-56021927 in participants with mild and moderate hepatic impairment.

Hepatic Impairment

Aragon Pharmaceuticals, Inc.24 participantsStarted Aug 2015

Knoxville, Tennessee, United States • San Antonio, Texas, United States

A Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction Potential After Single and Multiple Doses in Healthy Volunteers

Effects of Sodium Intake on Arterial Stiffness in Black Men and Women

A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function

Find Trials by Condition in Austin

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Avelumab in First-line NSCLC (JAVELIN Lung 100)

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences

A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion